How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/l-carnitine-high-dose.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

L-Carnitine ( high dose) — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

L-Carnitine ( high dose) (L-Carnitine ( high dose)) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Amino acid supplement / Metabolic agent. Area: Metabolic disorders, Cardiovascular, Neurology.

marketed Amino acid supplement / Metabolic agent Carnitine palmitoyltransferase (CPT) system Metabolic disorders, Cardiovascular, Neurology Small molecule Live · refreshed every 30 min

Target snapshot

L-Carnitine ( high dose) (L-Carnitine ( high dose)) — Ain Shams University. L-Carnitine facilitates the transport of long-chain fatty acids into mitochondria for β-oxidation, enhancing cellular energy production.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
L-Carnitine ( high dose) TARGET	L-Carnitine ( high dose)	Ain Shams University	marketed	Amino acid supplement / Metabolic agent	Carnitine palmitoyltransferase (CPT) system
L Carnitine ( low dose)	L Carnitine ( low dose)	Ain Shams University	marketed	Amino acid supplement / Metabolic agent	Carnitine palmitoyltransferase (CPT) system

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Amino acid supplement / Metabolic agent class)

Ain Shams University · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). L-Carnitine ( high dose) — Competitive Intelligence Brief. https://druglandscape.com/ci/l-carnitine-high-dose. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing